High Intensity Body-weight Circuit Training in Type 2 Diabetics
Feasibility of Minimal Dose High Intensity Body-weight Circuit Training in Type 2 Diabetics
1 other identifier
interventional
6
1 country
1
Brief Summary
Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characterized by periods of vigorous exercise alternated by periods of moderate exercise. Typical interval training sessions require significantly less time to complete than traditional modes of exercise wherein moderate intensity activity is sustained for some time. This may be especially beneficial to those with type 2 diabetes, as lack of time is a frequently cited reason for not engaging in regular exercise. Bodyweight circuit training carries the potential to similarly improve health and metabolic function in persons with type 2 diabetes, and may do so with even a smaller accumulation of exercise because this type of exercise involves a greater percentage of the trainee's muscle mass compared with common forms of interval training (e.g., treadmill or cycle exercise). The purpose of this study is to quantify the effects of 3-4 sessions per week of bodyweight circuit training sustained for 5-10 minutes per session on health-related physical fitness and glucose tolerance/control in people with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
August 11, 2020
CompletedFirst Posted
Study publicly available on registry
August 17, 2020
CompletedAugust 17, 2020
August 1, 2020
6 months
August 11, 2020
August 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline of HbA1c
glycosylated hemoglobin, marker of approximate three month blood glucose environment
16 weeks
Study Arms (1)
High Intensity Body-weight Circuit (HIBC)
EXPERIMENTALThe at home HIBC intervention program involved the use of both bodyweight and suspension training equipment (TRX® Fit System) with modified movements. The TRX® system was used to modify squats and rows while attached to the top of a door frame.
Interventions
HIBC Exercise Protocol- The HIBC circuit repetition and order is as follows: modified squats (10 repetitions), modified rows (5 repetitions), crunches (10 repetitions), and modified push-ups (5 repetitions). The exercise sessions involved repeating a series of repetitions of each movement in sequence, and completing as many sequences as possible in good form in the time allotted for the exercise (initially, 5 minutes). Participants were instructed to complete three sessions per week and documented the number of cycles completed. After 3 weeks of consistent training, participants were asked to add a 4th session each week as tolerated. Initially, the HIBC sessions were 5 minutes long, and the duration of the sessions were increased by one minute each week as tolerated beginning in week four, peaking at 10-minutes per session as early as the eighth week of training. Session duration was capped at 10 minutes.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Type 2 Diabetes of at least 1 year
- hemoglobin A1c level between 6.0% and 10%
You may not qualify if:
- Currently engaging in a physical activity
- Currently taking exogenous insulin
- Undertaking a regiment or lifestyle modification intervention.
- Cardiovascular or Pulmonary diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kennesaw State University
Kennesaw, Georgia, 30144-2381, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Kliszczewicz, PhD
Kennesaw State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2020
First Posted
August 17, 2020
Study Start
March 1, 2018
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
August 17, 2020
Record last verified: 2020-08